The EU is expected to take into account the level of vaccination coverage in a country such as the UK and its record in facilitating exports to the bloc when deciding on whether to prohibit individual vaccine shipments.
The revision of the export authorisation scheme, widening the criteria that will guide Brussels’ decisions on individual export requests, is due to be announced on Wednesday.
The move comes as UK and EU officials are seeking to avoid more damaging fallout from the row between Brussels and the Anglo-Swedish pharmaceutical company AstraZeneca.
The latest clash of interests has concerned an AstraZeneca facility in the Netherlands, and the competing demands of the EU and the UK on doses being produced. Officials in Brussels said they would probably block an export application from the plant if one were made.
To read the full article from The Guardian, please click here